Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

#24-92 Nischer Properties AB receives observation status

Nischer Properties AB ("the Company"), whose shares are listed on Nordic SME, disclosed a public takeover offer from Goldcup 35845 AB u.n.ä.t. Tailor BidCo AB to the shareholders in the Company. According to the Rules for companies whose shares are listed on Nordic SME, a company's shares can be placed under observation if the company is subject to a public takeover offer. With reference to the situation above, Nordic Growth Market NGM AB has decided to place the shares in the Company under observation with immediate effect. The observation status applies until further notice.

ABAX UK Announces Four New Sales Apprenticeships

ABAX UK, a leading provider of telematics and fleet management solutions, is proud to announce the creation of four new sales apprenticeship positions as part of its ongoing commitment to local talent development and business growth. Based at the Weston Homes Stadium in Peterborough, this initiative aims to equip individuals with the skills they need to thrive in the ever-evolving technology and sales landscape.For Immediate Release Peterborough, UK – 23/09/2024 ABAX UK Expands Local Workforce with Four New Sales Apprenticeships Key Highlights: 1.Local Job Creation: These

Read original

BPC Instruments launches the BPC Titan – a new solution for gas flow and volume monitoring in pilot and small scales fermentation processes

BPC Instruments AB (publ) (“BPC”) announces the global launch of its latest innovation, the BPC Titan, specifically designed for biological fermentation processes involving high gas production. Building on the success of the BPC Go, the BPC Titan extends to new market niches, improving the efficiency and precision of gas flow and volume measurement across applications such as biogas production, ethanol fermentation, biohydrogen generation, and other microbial fermentation processes.BPC launches its latest innovation, the BPC Titan, designed to enhance the efficiency and accuracy of gas

Södra signs agreement to supply Stora Enso with kraft lignin from world-leading new plant

Södra confirms Stora Enso among the first customers for kraft lignin. This follows the major investment announcement earlier this year regarding kraft lignin production at Södra’s Mönsterås site. The plant will be the first commercial kraft lignin production facility in Sweden and the largest of its type in the world. It is expected to be in operation in 2027.Stora Enso has developed lignin expertise and know-how over the past decade and runs its own pilot plant for battery material. Stora Enso has a strong believe in lignin and is now in need of an external source of the raw material.

Repurchase of Truecaller B shares in week 38, 2024

During 16 September 2024 and 20 September 2024 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 150,000 own B shares (ISIN: SE0016787071), corresponding to 0.04% of outstanding capital, as part of the share buyback programme initiated by the board of directors. Since the start of the programme, in the end of May, 3.17 million B-shares has been repurchased which corresponds to 0.90% of the outstanding capital.The share buybacks form part of the share buyback programme announced by Truecaller on 28 May 2024. The share buyback programme will run between 28 May up

Hospital in Greenland chooses Sectra’s radiology solution—enhanced cross-country collaboration for improved patient care

Linköping, Sweden – September 23, 2024 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) will provide its enterprise imaging solution to Dronning Ingrids hospital (DIH) in Greenland. The solution will enhance DIH’s ongoing collaboration with hospitals in Denmark, addressing resource and subspecialty challenges, and ultimately improving patient care in the region.“The partnerships we have with hospitals in Denmark are highly important to us as we, being sparsely populated, struggle to recruit staff and cover medical specialties locally.

Atlas Copco Group appoints Koen Lauwers President of the Vacuum Technique business area

Nacka, Sweden, September 23, 2024: Atlas Copco Group has appointed Koen Lauwers President of the Vacuum Technique business area and member of Group Management, effective January 1, 2025. Koen Lauwers is currently President for the Semiconductor division within the same business area.“Koen is a passionate and respected leader, and he has a broad experience”, said Vagner Rego, President & CEO of Atlas Copco Group. “Through the years he has delivered strong business results and created high value solutions for our customers. I am very pleased that he has agreed to take on this role.” Koen

NYAB signs multi-year framework agreements for energy projects

NYAB Sverige has secured framework agreements for local network projects in Northern Norrland and the Malmfälten region. These agreements, spanning three years with an option for extension for an additional four years, guarantee a project volume of SEK 195 million over the initial contract period.The client is Vattenfall Eldistribution, and the framework agreements continue until the end of 2027. The guaranteed project volume amounts to SEK 40 million per year for the Northern Norrland area and SEK 25 million per year for the Malmfälten area. Projects will be executed as either turnkey

Fasenra recommended for EU approval in EGPA

23 September 2024 Fasenrarecommended for approval in the EU by CHMP for the treatment ofeosinophilic granulomatosis with polyangiitisNew indication supported by the MANDARA trial which showed nearly 60% of patientsachieved remission and 41% of patients fully stopped taking oral corticosteroids  AstraZeneca's Fasenra (benralizumab) has been recommended for approval in the European Union (EU) as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis (EGPA). EGPA is a rare, immune-mediated vasculitis that can result in

NYAB appoints Mårten Beijar as HR Director and member of the Executive Management Team

NYAB has appointed Mårten Beijar as HR Director of the Group and new member of the Executive Management Team. He will be responsible for strategic management and development of NYAB’s HR activities and will participate in the development of NYAB’s sustainability-related processes. He will start in his position on 7 October 2024. Beijar has extensive international experience in HR leadership. Before joining NYAB, he worked at Fibox Group since 2021, most recently as Executive Vice President, Head of People, Culture and ESG. Previously, he has been HR Director at, among others, Rexel Group

Kemira expands ASA sizing agents capacity in Nanjing, China to respond to increased market demand

Kemira Oyj, Press release, September 23, 2024 at 9.00 EESTKemira expands ASA sizing agents capacity in Nanjing, China to respond to increased market demand   Kemira, the leading ASA (alkenyl succinic anhydride) producer and supplier in Asia-Pacific region has completed a multimillion euro investment to expand the production capacity of ASA sizing agents at its Nanjing site in Jiangsu province in China. The scope of the investment includes a full third production line and additional storage and tank capacity to further improve customer deliveries and supply reliability.   ASA

Final OS results reported for TROPION-Breast01

23 September 2024 Datopotamab deruxtecan final overall survival results reported inpatients with metastatic HR-positive, HER2-low or negative breast cancer inTROPION-Breast01 Phase III trial  Survival results for AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan in TROPION-Breast01 did not achieve statistical significance versus chemotherapy Trial previously met the dual primaryendpoint of progression-free survival High-level results from the TROPION-Breast01 Phase III trial of datopotamab deruxtecan (Dato-DXd) compared to investigator's choice of chemotherapy,

Chief Financial Officer Aku Väliaho leaves NYAB

Aku Väliaho, CFO, has decided to leave NYAB to assume a position outside the Group. Väliaho has been a member of NYAB’s Executive Management Team since January 2022, and he will continue in his role until the end of January 2025. NYAB has started a process to recruit a new CFO for the Company. “I am grateful towards Aku for his significant contribution to NYAB. He has had a vital role in building today’s NYAB by managing our milestone processes such as the reverse acquisition and merger of NYAB and Skarta, transferring our financial reporting to IFRS, successful re-domiciliation to

Fortum to sell its stakes in the biobased solutions businesses in India

FORTUM CORPORATION INVESTOR NEWS 23 SEPTEMBER 2024 AT 9:00 EEST Fortum has signed an agreement to sell its 37.4% ownership in Chempolis Oy, including Fortum’s all biobased solutions businesses, and the shares in the holding company owning 40.3% in Assam Bio Ethanol Pvt Ltd in India to the Indian leading energy transition solutions provider AM Green Technology & Solutions B.V. The transaction will not have any material financial impact on Fortum Group’s result. The transactions are subject to certain closing conditions. The divestment of the biobased solutions businesses is part of

Seventy Agency, a Company Within Lyvia Group, Creates Visuals Concepts for Global Samsung Product Launches

September 23, 2024 - Stockholm, Sweden: Seventy Agency is expanding its global reach through a strategic collaboration with the tech giant Samsung. In the spring of 2024, the agency entered a key partnership with Samsung’s headquarters in Suwon, South Korea, marking a significant milestone in their international efforts.The first results of this collaboration have now been unveiled, with Seventy Agency playing a crucial role in crafting the creative and visual concepts for two major Samsung product launches: the Galaxy Book4 Edge and the Galaxy Ring. These visuals form the core of Samsung’s

Interim Results

23 September 2024     Quantum Blockchain Technologies plc ("QBT", “the Group” or "the Company")     INTERIM RESULTS   Quantum Blockchain Technologies (AIM: QBT), the AIM-listed investment company focusing on a R&D and investment programme within blockchain technology, is pleased to announce its Interim Results for the six months ended 30 June 2024.     For further information please contact:   Quantum Blockchain Technologies Plc Francesco Gardin, CEO and Executive Chairman  +39 335 296573   SP Angel Corporate Finance (Nominated Adviser &

Skanska selected for reservoir construction project in Yonkers, NY, USA, for USD 630M, about SEK 6.6 billion

Skanska has, in a joint venture with ECCO III Enterprises, Inc., signed a contract with the New York City Department of Environmental Protection (NYCDEP) for the Hillview Reservoir Chemical Addition Facilities Construction project in Yonkers, New York, USA. The project is mandated by the Hillview Reservoir Consent Decree and Judgment. The contract is worth USD 848M. Skanska will include its 75 percent share of the contract worth USD 630M, about SEK 6.6 billion, in the US order bookings for the third quarter of 2024.The project scope includes upgrades to the existing North Entrance and the

Sweco to design new kind of mycoprotein plant in Finland

Finnish biotech start-up company Enifer has awarded Sweco a new contract to establish a new plant for the industrial production of mycoprotein. Production starts in 2026, and the plant will be the world's first to utilise side streams from food production on a commercial scale in an industrial symbiosis. Sweco will deliver services for project management, plant design, building permits, procurement and construction management in a project valued at EUR 4.2 million.(Press photo showing mycoprotein, for free use, please credit photographer: Enifer/Iiro Muttilainen)Mycoprotein is a high-

Read original

Aker ASA: Mandatory Notification of Trade

Reference is made to the stock exchange notice by Aker BP ASA ("Aker BP") today regarding Aker BP's annual share purchase programme.Sofie Valdersnes, employee elected board member in Aker ASA and employee in Aker BP, has purchased 546 shares in Aker BP and Håkon Enerstvedt, a person closely associated to Sofie Valdersnes and employee in Aker BP, has purchased 546 shares. The shares in Aker BP are purchased at a discounted price of NOK 182.87 per share, which represents a 20 percent discount to the reference market price, and the shares are subject to a three-year lock-up period.

Employees buy shares in Aker BP

Aker BP has received subscriptions from employees for more than 1.2 million shares at a discounted price of NOK 182.87 per share through the company’s annual share purchase programme. The subscription price represents a 20 percent discount to the reference market price, and the shares are subject to a three-year lock-up period. Approximately 62 percent of the company's employees subscribed in the program, including the following primary insiders: Primary Position  Shares purchased  New holdinginsiderTalar Arif SVP Ula

There are no items matching the current filter
There are no more items matching the current filter
Back to top